Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Roaring Internet Stocks -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (749)	1/8/1999 12:28:00 PM
From: GARY P GROBBEL	Respond to of 1530

DIMG (1.75/1.81) on 40k has release out today...I have been a DIMG fan for some time now and I think we will be hearing more from the company going forward ref their A/V Daily News like today's release w/RealNetworks. gpg

To: GARY P GROBBEL who wrote (749)	1/8/1999 12:30:00 PM
From: Travis McGee	Read Replies (1) \| Respond to of 1530

(could not resist a little scep) WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Jan. 8, 1999--Franklin Telecom (OTC BB:FTEL) Friday announced that its Tempest Data Voice Gateway® has been named Product of the Year for UNIX-based Gateways by Internet Telephony magazine. hmmm.... biz.yahoo.com

To: GARY P GROBBEL who wrote (749)	1/8/1999 12:42:00 PM
From: GARY P GROBBEL	Respond to of 1530

Here is add'l info on SCEP... Medisys Technologies, Inc. and Phillips Pharmatec Labs, Inc. Shareholders Approve Acquisition/Merger BATON ROUGE, La. and LARGO, Fla.--(BUSINESS WIRE)--Jan. 5, 1999-- Medisys® Technologies, Inc., (Medisys®) (OTCBB:SCEP - news) announced today the overwhelming approval of its shareholders to the acquisition of Phillips Pharmatec Labs, Inc. (PPL) a private company based in Largo, Florida. The voting shareholders of both companies voted over 90% approval of the agreement for Medisys® to acquire Phillips and merge the complimentary assets of the two companies. The complimentary combination of Phillips assembly and manufacturing capabilities and Medisys® broad-based patented products, results in a merged company that expects substantial growth from the current profitable base of approximately $3.5 million sales in 1998 by the Phillips division. ''While the original agreement called for $3 to $5 million capital raised for the transaction, both boards agreed to reduce this amount to only $750,000 to break escrow based on the positive outlook for the merged businesses.'' Noted Ed Sutherland Medisys® CEO, ''The Company will ultimately seek additional capital for further expansion but should be able to generate substantial growth with this initial investment. At a later date the Company would expect to announce a secondary funding offer based on expected growth projections.'' In addition to the expansion plans of PPL, Medisys® has patented products such as the VetCeps(tm) Animal Birth Assistance Device, the DiskLip(tm) Medical Tubing Management System, and the RETY(tm) Adjustable Reusable Cable Tie Systems available for immediate sales. The CoverTip(tm) Safety Syringe has received FDA 510K clearance to be marketed into the U.S. one billion-dollar syringe marketplace. Each of these products are at the threshold of market introduction with anticipated revenue in 1999. Medisys® Technologies, Inc. has thirteen U.S. patents covering these safety devices and other products. The Company also has over 20 patent applications pending for protection of medical devices both in the United States and overseas in the areas of women's health, lifeline management, medical safety and other specialty revenue markets. The PPL business unit currently produces nutritional, health and dietary products as well as pharmaceuticals with consistent profitability and 1997 sales of approximately $3.6 Million. Phillips manufactures over 350 products for a customer base of over 100 nutriceutical and pharmaceutical companies that market to major drug, food, health and wellness chains throughout the U.S. PPL is a contract manufacturer business unit owned and operated under the name and public umbrella of Medisys® Technologies, Inc. PPL provides Medisys® with general revenue and cash flow during the development phase of its over 20 patented medical devices. Statements in this release may be construed to be forward looking and are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward looking statements involve risks and uncertainties, including, but not limited to, risks associated with regulatory approvals, lack of adequate capitalization and/or other risks inherent in medical device and other product development. Contact: Ed Sutherland/Kerry Frey